In prostate cancer cells, we see a similar phenotype; Du145 and PC-3 cells that overexpress Axl are intrinsically resistant to metformin and have an EMT phenotype and knock down of Axl renders the cells more sensitive to metformin. Here, AXL is linked to prostate carcinoma.